Motew S J, Sam A D, Mourelatos M G, Sharma A C, Alden K J, Ferguson J L, Law W R
Department of Surgery, University of Illinois College of Medicine at Chicago, Chicago, Illinois, 60612, USA.
J Surg Res. 1998 Dec;80(2):326-32. doi: 10.1006/jsre.1998.5427.
To identify vascular beds where endogenous adenosine plays a significant role as a mediator of resting perfusion alterations associated with sepsis, we tested the hypothesis that adenosine receptor blockade would cause differential regional increases in vascular resistance during intraperitoneal (ip) sepsis in the rat.
Rats (250-350 g) were catheterized and randomized to septic or nonseptic groups. Sepsis was induced with an ip injection of cecal slurry (150 mg/kg in D5W; 5 ml/kg), and baseline hemodynamics, cardiac output (CO), and blood flows (microspheres) were measured 24 h later. Animals then received the adenosine receptor antagonist 8-phenyltheophylline (8-PTH; 10 mM, 1.5 ml/kg), its vehicle (1.5 ml/kg), or normal saline (1.5 ml/kg), iv, and measurements were repeated.
Septic animals treated with 8-PTH had a significant increase in skeletal muscle, hepatic portal, and cerebral vascular resistance with concomitant decreases in CO when compared with vehicle at 1 min. No significant resistance changes were observed in the renal, adipose, or coronary vasculatures. Adenosine receptor blockade caused a significant increase in +dP/dt and -dP/dt during sepsis, indicating that the reduced CO was not secondary to myocardial depression.
These data suggest that adenosine receptor-mediated actions during sepsis affect vascular beds selectively and indicate a significant role for adenosine in resting perfusion redistribution in sepsis.
为了确定内源性腺苷作为与脓毒症相关的静息灌注改变的介质发挥重要作用的血管床,我们测试了以下假设:在大鼠腹腔内(ip)脓毒症期间,腺苷受体阻断会导致不同区域的血管阻力增加。
将大鼠(250 - 350 g)插管并随机分为脓毒症组或非脓毒症组。通过腹腔注射盲肠匀浆(在5%葡萄糖水溶液中为150 mg/kg;5 ml/kg)诱导脓毒症,24小时后测量基线血流动力学、心输出量(CO)和血流量(微球法)。然后动物静脉注射腺苷受体拮抗剂8 - 苯基茶碱(8 - PTH;10 mM,1.5 ml/kg)、其溶媒(1.5 ml/kg)或生理盐水(1.5 ml/kg),并重复测量。
与溶媒组相比,接受8 - PTH治疗的脓毒症动物在1分钟时骨骼肌、肝门静脉和脑血管阻力显著增加,同时CO降低。在肾、脂肪或冠状血管系统中未观察到显著的阻力变化。腺苷受体阻断在脓毒症期间导致 +dP/dt和 -dP/dt显著增加,表明CO降低并非继发于心肌抑制。
这些数据表明,脓毒症期间腺苷受体介导的作用选择性地影响血管床,并表明腺苷在脓毒症静息灌注再分布中起重要作用。